These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

792 related items for PubMed ID: 14963199

  • 21. An update on methotrexate.
    Braun J, Rau R.
    Curr Opin Rheumatol; 2009 May; 21(3):216-23. PubMed ID: 19373092
    [Abstract] [Full Text] [Related]

  • 22. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis.
    Jansen G, van der Heijden J, Oerlemans R, Lems WF, Ifergan I, Scheper RJ, Assaraf YG, Dijkmans BA.
    Arthritis Rheum; 2004 Jul; 50(7):2130-9. PubMed ID: 15248210
    [Abstract] [Full Text] [Related]

  • 23. [Methotrexate for the treatment of rheumatoid arthritis in Japan--much more still remains to be resolved].
    Suzuki Y.
    Nihon Rinsho; 2002 Dec; 60(12):2331-8. PubMed ID: 12510358
    [Abstract] [Full Text] [Related]

  • 24. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
    James HM, Gillis D, Hissaria P, Lester S, Somogyi AA, Cleland LG, Proudman SM.
    J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
    [Abstract] [Full Text] [Related]

  • 25. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Shea B, Swinden MV, Ghogomu ET, Ortiz Z, Katchamart W, Rader T, Bombardier C, Wells GA, Tugwell P.
    J Rheumatol; 2014 Jun; 41(6):1049-60. PubMed ID: 24737913
    [Abstract] [Full Text] [Related]

  • 26. Longterm methotrexate use in rheumatoid arthritis: 12 year followup of 460 patients treated in community practice.
    Wluka A, Buchbinder R, Mylvaganam A, Hall S, Harkness A, Lewis D, Littlejohn GO, Miller MH, Ryan PF.
    J Rheumatol; 2000 Aug; 27(8):1864-71. PubMed ID: 10955325
    [Abstract] [Full Text] [Related]

  • 27. Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis.
    Hoekstra M, van de Laar MA, Bernelot Moens HJ, Kruijsen MW, Haagsma CJ.
    J Rheumatol; 2003 Nov; 30(11):2325-9. PubMed ID: 14677172
    [Abstract] [Full Text] [Related]

  • 28. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
    Berkun Y, Abou Atta I, Rubinow A, Orbach H, Levartovsky D, Aamar S, Arbel O, Dresner-Pollak R, Friedman G, Ben-Yehuda A.
    J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
    [Abstract] [Full Text] [Related]

  • 29. Folate supplementation during methotrexate therapy for rheumatoid arthritis.
    Morgan SL, Baggott JE.
    Clin Exp Rheumatol; 2010 Aug; 28(5 Suppl 61):S102-9. PubMed ID: 21044441
    [Abstract] [Full Text] [Related]

  • 30. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK, O'Donnell JL, Chapman PT, Zhang M, Frampton C, James J, Barclay ML.
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [Abstract] [Full Text] [Related]

  • 31. Correlation between methotrexate efficacy & toxicity with C677T polymorphism of the methylenetetrahydrofolate gene in rheumatoid arthritis patients on folate supplementation.
    Aggarwal P, Naik S, Mishra KP, Aggarwal A, Misra R.
    Indian J Med Res; 2006 Nov; 124(5):521-6. PubMed ID: 17213520
    [Abstract] [Full Text] [Related]

  • 32. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
    van Ede AE, Laan RF, Blom HJ, Boers GH, Haagsma CJ, Thomas CM, De Boo TM, van de Putte LB.
    Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
    [Abstract] [Full Text] [Related]

  • 33. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators.
    Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331
    [Abstract] [Full Text] [Related]

  • 34. Folic acid alters methotrexate availability in patients with rheumatoid arthritis.
    Bressolle F, Kinowski JM, Morel J, Pouly B, Sany J, Combe B.
    J Rheumatol; 2000 Sep; 27(9):2110-4. PubMed ID: 10990220
    [Abstract] [Full Text] [Related]

  • 35. Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis.
    Dervieux T, Greenstein N, Kremer J.
    Arthritis Rheum; 2006 Oct; 54(10):3095-103. PubMed ID: 17009228
    [Abstract] [Full Text] [Related]

  • 36. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
    Maradit-Kremers H, Nicola PJ, Crowson CS, O'Fallon WM, Gabriel SE.
    J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
    [Abstract] [Full Text] [Related]

  • 37. Prospectively measured red cell folate levels in methotrexate treated patients with rheumatoid arthritis: relation to withdrawal and side effects.
    Andersen LS, Hansen EL, Knudsen JB, Wester JU, Hansen GV, Hansen TM.
    J Rheumatol; 1997 May; 24(5):830-7. PubMed ID: 9150068
    [Abstract] [Full Text] [Related]

  • 38. Methotrexate update.
    Kremer JM.
    Scand J Rheumatol; 1996 May; 25(6):341-4. PubMed ID: 8996467
    [Abstract] [Full Text] [Related]

  • 39. Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?
    McLean-Tooke A, Aldridge C, Waugh S, Spickett GP, Kay L.
    Rheumatology (Oxford); 2009 Aug; 48(8):867-71. PubMed ID: 19447771
    [Abstract] [Full Text] [Related]

  • 40. Disappointing longterm results with disease modifying antirheumatic drugs. A practice based study.
    Galindo-Rodriguez G, Aviña-Zubieta JA, Russell AS, Suarez-Almazor ME.
    J Rheumatol; 1999 Nov; 26(11):2337-43. PubMed ID: 10555887
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.